Interestingly, there is a reduction in the expression of CD39 and CD73 in B cells from COVID-19 patients and the CD19+CD39+CD73+ population is diminished in patients regardless of the disease status (Figure 2C). The gene discussed is ENTPD1; the disease is COVID-19.